Merus NV (MRUS)
96.78
+0.42
(+0.44%)
USD |
NASDAQ |
Dec 10, 16:00
96.78
0.00 (0.00%)
After-Hours: 20:00
Merus Profit Margin (Quarterly): -786.2% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Genmab A/S | 39.24% |
| uniQure NV | -2.18K% |
| ProQR Therapeutics NV | -381.9% |
| argenx SE | -- |
| Pharming Group NV | 7.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -53.47% |
| Return on Assets | -44.89% |
| Return on Invested Capital | -52.67% |
| Gross Profit Margin (Quarterly) | 94.71% |
| Operating Margin (Quarterly) | -794.1% |
| Return on Net Operating Assets | -580.1% |